Gene M. Williams

2.0k total citations
18 papers, 1.7k citations indexed

About

Gene M. Williams is a scholar working on Cellular and Molecular Neuroscience, Physiology and Molecular Biology. According to data from OpenAlex, Gene M. Williams has authored 18 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Cellular and Molecular Neuroscience, 6 papers in Physiology and 5 papers in Molecular Biology. Recurrent topics in Gene M. Williams's work include Pain Mechanisms and Treatments (6 papers), Neurotransmitter Receptor Influence on Behavior (4 papers) and Neuropeptides and Animal Physiology (4 papers). Gene M. Williams is often cited by papers focused on Pain Mechanisms and Treatments (6 papers), Neurotransmitter Receptor Influence on Behavior (4 papers) and Neuropeptides and Animal Physiology (4 papers). Gene M. Williams collaborates with scholars based in United States. Gene M. Williams's co-authors include Ronald Dubner, M.A. Ruda, Ke Ren, Janice L.K. Hylden, Richard Pazdur, Rajeshwari Sridhara, Brian Booth, Ann T. Farrell, Robert Justice and David E. Morse and has published in prestigious journals such as Brain Research, Clinical Cancer Research and Pain.

In The Last Decade

Gene M. Williams

18 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gene M. Williams United States 15 656 590 452 336 230 18 1.7k
Jianliang Zhang China 27 525 0.8× 751 1.3× 189 0.4× 317 0.9× 139 0.6× 75 2.1k
Pei‐Hsin Huang Taiwan 24 438 0.7× 893 1.5× 376 0.8× 252 0.8× 127 0.6× 54 1.9k
Margaret L. Ramnaraine United States 19 891 1.4× 687 1.2× 269 0.6× 742 2.2× 132 0.6× 38 2.0k
William M. Isenberg United States 17 437 0.7× 377 0.6× 279 0.6× 149 0.4× 157 0.7× 26 1.4k
N Oggioni Italy 26 675 1.0× 540 0.9× 299 0.7× 1.2k 3.4× 185 0.8× 55 2.2k
Valentina Carozzi Italy 26 690 1.1× 550 0.9× 312 0.7× 1.3k 3.8× 244 1.1× 66 2.2k
Donald C. Manning United States 20 555 0.8× 485 0.8× 455 1.0× 266 0.8× 165 0.7× 36 1.7k
Nathalie Blin France 17 498 0.8× 947 1.6× 467 1.0× 270 0.8× 104 0.5× 29 1.6k
Kai‐Yin Chau United Kingdom 29 838 1.3× 1.5k 2.5× 403 0.9× 250 0.7× 137 0.6× 59 3.4k
Stefan Quasthoff Germany 29 705 1.1× 991 1.7× 825 1.8× 1.1k 3.4× 219 1.0× 72 3.3k

Countries citing papers authored by Gene M. Williams

Since Specialization
Citations

This map shows the geographic impact of Gene M. Williams's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gene M. Williams with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gene M. Williams more than expected).

Fields of papers citing papers by Gene M. Williams

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gene M. Williams. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gene M. Williams. The network helps show where Gene M. Williams may publish in the future.

Co-authorship network of co-authors of Gene M. Williams

This figure shows the co-authorship network connecting the top 25 collaborators of Gene M. Williams. A scholar is included among the top collaborators of Gene M. Williams based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gene M. Williams. Gene M. Williams is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Norsworthy, Kelly J., Lola Luo, Vicky Hsu, et al.. (2019). FDA Approval Summary: Ivosidenib for Relapsed or Refractory Acute Myeloid Leukemia with an Isocitrate Dehydrogenase-1 Mutation. Clinical Cancer Research. 25(11). 3205–3209. 102 indexed citations
2.
Malik, Shakun, Ke Liu, Qiang Xu, et al.. (2010). Folotyn (Pralatrexate Injection) for the Treatment of Patients with Relapsed or Refractory Peripheral T-Cell Lymphoma: U.S. Food and Drug Administration Drug Approval Summary. Clinical Cancer Research. 16(20). 4921–4927. 38 indexed citations
3.
Hazarika, Maitreyee, Edwin P. Rock, Gene M. Williams, et al.. (2008). Lenalidomide in Combination with Dexamethasone for the Treatment of Multiple Myeloma After One Prior Therapy. The Oncologist. 13(10). 1120–1127. 25 indexed citations
4.
Kane, Robert C., Ann T. Farrell, Haleh Saber, et al.. (2006). Sorafenib for the Treatment of Advanced Renal Cell Carcinoma. Clinical Cancer Research. 12(24). 7271–7278. 398 indexed citations
5.
Johnson, John R., Martin H. Cohen, Rajeshwari Sridhara, et al.. (2005). Approval Summary for Erlotinib for Treatment of Patients with Locally Advanced or Metastatic Non–Small Cell Lung Cancer after Failure of at Least One Prior Chemotherapy Regimen. Clinical Cancer Research. 11(18). 6414–6421. 179 indexed citations
6.
Bross, Peter, Gang Chen, Richard T. Lostritto, et al.. (2003). Fulvestrant in postmenopausal women with advanced breast cancer.. PubMed. 9(12). 4309–17. 46 indexed citations
7.
Ren, Ke, Gene M. Williams, M.A. Ruda, & Ronald Dubner. (1994). Inflammation and hyperalgesia in rats neonatally treated with capsaicin: effects on two classes of nociceptive neurons in the superficial dorsal horn. Pain. 59(2). 287–300. 38 indexed citations
8.
Thomas, David A., Fernand Anton, Daniel R. Kenshalo, Gene M. Williams, & Ronald Dubner. (1993). Noradrenergic and opioid systems interact to alter the detection of noxious thermal stimuli and facial scratching in monkeys. Pain. 55(1). 63–70. 9 indexed citations
9.
Caudle, Robert M. & Gene M. Williams. (1993). The misuse of analysis of variance to detect synergy in combination drug studies. Pain. 55(3). 313–317. 26 indexed citations
10.
Williams, Gene M., et al.. (1993). The Medullary Dorsal Horn. Anesthesiology. 79(3). 548–554. 62 indexed citations
11.
Williams, Gene M., et al.. (1993). Multiple Effects of Morphine on Facial Scratching in Monkeys. Anesthesia & Analgesia. 77(5). 933???935–933???935. 24 indexed citations
12.
Williams, Gene M., et al.. (1992). 5-HT3 receptors are not involved in the modulation of the K+-evoked release of [3H]5-HT from spinal cord synaptosomes of rat. Neuropharmacology. 31(8). 725–733. 12 indexed citations
13.
Thomas, D. A., Gene M. Williams, Koichi Iwata, Dan R. Kenshalo, & Ronald Dubner. (1992). Effects of central administration of opioids on facial scratching in monkeys. Brain Research. 585(1-2). 315–317. 68 indexed citations
14.
Ren, Ke, Gene M. Williams, Janice L.K. Hylden, M.A. Ruda, & Ronald Dubner. (1992). The intrathecal administration of excitatory amino acid receptor antagonists selectively attenuated carrageenan-induced behavioral hyperalgesia in rats. European Journal of Pharmacology. 219(2). 235–243. 212 indexed citations
15.
Ren, Ke, Janice L.K. Hylden, Gene M. Williams, M.A. Ruda, & Ronald Dubner. (1992). The effects of a non-competitive NMDA receptor antagonist, MK-801, on behavioral hyperalgesia and dorsal horn neuronal activity in rats with unilateral inflammation. Pain. 50(3). 331–344. 371 indexed citations
16.
Brown, Laurie M., Deborah L. Smith, Deborah L. Smith, et al.. (1989). Alterations in serotonin binding sites after 5,7-dihydroxytryptamine treatment in the rat spinal cord. Neuroscience Letters. 102(1). 103–107. 25 indexed citations
17.
Brown, Laurie M., et al.. (1988). A pharmacological analysis of the rat spinal cord serotonin (5-HT) autoreceptor. European Journal of Pharmacology. 145(2). 163–171. 16 indexed citations
18.
Azzaro, A.J., et al.. (1988). The effect of selective type A or type B monoamine oxidase inhibition on the intrasynaptosomal deamination of (3H)serotonin in rat spinal cord tissue. Naunyn-Schmiedeberg s Archives of Pharmacology. 338(1). 9–13. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jianliang Zhang Breakdown of academic impact, for papers by Pei‐Hsin Huang Breakdown of academic impact, for papers by Margaret L. Ramnaraine Breakdown of academic impact, for papers by William M. Isenberg Breakdown of academic impact, for papers by N Oggioni Breakdown of academic impact, for papers by Valentina Carozzi Breakdown of academic impact, for papers by Donald C. Manning Breakdown of academic impact, for papers by Nathalie Blin Breakdown of academic impact, for papers by Kai‐Yin Chau Breakdown of academic impact, for papers by Stefan Quasthoff
Rankless by CCL
2026